Jose Canseco and Human Genetic Engineering
By Osagie Obasogie,
Cincinnati Enquirer
| 10. 21. 2005
Will He Be Right Again?
Recently, Jose Canseco and I were guests on a talk show to discuss gene doping, the genetic equivalent to anabolic steroids - a way to "juice up" to gain a competitive edge. It is possible that in the next few years athletes will be able to enhance their performance by altering their genetic make-ups. Canseco argued that gene doping "is definitely the next big step in evolution." Genetic enhancement, he said, "goes way beyond sports. Imagine an army of a million individuals who can out-think, out-use the environment in the sense of less food, more reaction time, better vision, better physical reaction . . . (T)he human race . . . is going to evolve and no one's gonna stop it."
It's easy to dismiss this as the ramblings of a B-list star struggling to keep himself in the limelight. Indeed, when Canseco released his now infamous "Juiced: Wild Times, Rampant 'Roids, Smash Hits, and How Baseball Got Big," this was most people's response. Yet we have been forced to swallow the bitter truthfulness of Canseco's pill. In the few...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...